Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GT Biopharma (GTBP) Minority Interest (2016 - 2021)

GT Biopharma (GTBP) has disclosed Minority Interest for 10 consecutive years, with -$169000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Minority Interest changed 0.0% to -$169000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was -$169000.0, a 0.0% change, with the full-year FY2020 number at -$169000.0, changed 0.0% from a year prior.
  • Minority Interest was -$169000.0 for Q1 2021 at GT Biopharma, roughly flat from -$169000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$169000.0 in Q4 2017 to a low of -$169000.0 in Q4 2017.
  • A 5-year average of -$169000.0 and a median of -$169000.0 in 2017 define the central range for Minority Interest.
  • Biggest YoY gain for Minority Interest was 0.0% in 2017; the steepest drop was 0.0% in 2017.
  • GT Biopharma's Minority Interest stood at -$169000.0 in 2017, then changed by 0.0% to -$169000.0 in 2018, then changed by 0.0% to -$169000.0 in 2019, then changed by 0.0% to -$169000.0 in 2020, then changed by 0.0% to -$169000.0 in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Minority Interest are -$169000.0 (Q1 2021), -$169000.0 (Q4 2020), and -$169000.0 (Q3 2020).